5th April 2017

  • Order received for AUD $0.65 million for Austco’s state of the art Nurse call system
  • Staff Presence solution will be used to improve staff efficiency and patient care
  • Bi-Directional audio will streamline communication between patients and nursing staff
  • Anti-bacterial handsets will provide television and lighting controls

Wednesday, 5 April 2017 – Melbourne – Azure Healthcare Limited (ASX:AZV)…

read more...

 Melbourne, Australia, February 28 2017 – Azure Healthcare Limited (ASX:AZV) attaches its half year report for the 6 months ended 31 December 2016.

 Summary:

  • The net loss after tax for the half year ended 31 December 2016 was $4.56 million, which included one off restructuring costs, provisions and balance sheet impairments of…

    read more...

28 January 2017

Austco Communication Systems Pty Ltd, a wholly owned subsidiary of Azure Healthcare Ltd (ASX:AZV), today announced the official launch of Pulse RTLS. Pulse RTLS is the second module in the evolution of Austco’s innovative Tacera Pulse software suite and represents an important milestone in the company’s development…

read more...

23 December 2016

Further to the announcement on 7 November 2016, Azure Healthcare Limited (ACN 108 208 760) (ASX: AZV) (Azure or the Company) is pleased to announce that its wholly owned subsidiary Austco Communication Systems Pty Ltd (ACN 009 195 984) (Austco) has today completed the sale of the…

read more...

2016 AGM CEO’s Address

Azure Healthcare 2016 Annual General Meeting Chief Executive Officer’s Address.

Read Official Release Here

For further information, please contact:

Mr Jason D’Arcy
Company Secretary
Telephone AUS: +614 1767 7732
Telephone US: +1 214 930 2233
Email: jason.darcy@azurehealthcare.com.au

read more...

Categories

2016 AGM Chairman’s Address

Good afternoon Ladies and Gentlemen,

The 2016 financial year was a challenging year as your company commenced a significant review and restructure of operations. Some of these initiatives included the transition of manufacturing to the USA, product review and rationalisation and full FDA regulatory compliance and research and development initiatives. The Directors are confident that these initiatives…

read more...

Categories

Azure Healthcare Limited (ACN 108 208 760) (ASX: AZV) (Azure or the Company) is pleased to announce the successful placement of 28,456,731 new fully paid ordinary shares in the Company to sophisticated, professional and institutional investors at an issue price of $0.070 per share, to raise $1,991,971 (Placement).

In conjunction with the…

read more...

Categories

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the outcome of each resolution put to the Annual General Meeting of Azure Healthcare Limited conducted on 25 November 2016 and the number of proxies received in respect of each resolution as set out in…

read more...

Categories

Thursday, 24 November 2016 ‐ Austco Communication Systems Pty Ltd and Azure Healthcare Ltd (ASX:AZV) are pleased to announce the appointment of Mike Read as General Manager of Austco’s Australian operations. He will report directly to Chief Executive Officer, Clayton Astles.

“Mike has built an impressive track record of strategic…

read more...

Categories

Sale of CellGuard Business

  • Austco Communication Systems Pty Ltd (subsidiary of Azure Healthcare Limited) has entered into a binding Term Sheet for the sale of its CellGuard business, for upfront consideration of $1m.
  • Transaction is consistent with Azure’s ongoing strategic restructuring programme to optimise shareholder value, in part, through the rationalisation of non-core assets.

Azure…

read more...